Search Results

Site Search

Microlearning: All the Small Things - Insights

As the saying often goes, “It’s the small things that matter the most.” Jeremy Zacher, Education Specialist in the Department of Laboratory Medicine and Pathology, discusses "microlearning" as a way of delivering learning content in...

Coaching for Staff Development - Insights

"Coaching" has become the latest buzzword on the staff-development scene. In its purest form, coaching is a developmental process carried out between the coach and a "talent" in order to promote desirable and sustainable change.

Twitter as a Microblog Platform - Insights

Justin Kreuter, M.D., highlights how professional networks can be nurtured continuously throughout the year with the help of Twitter.

A Sysmex Game of Telephone - Insights

Rachel Olk, a student in the Mayo Clinic Medical Laboratory Science class of 2018, talks about her experience with the Sysmex Hematology Analyzer during a game of "Telephone" in the laboratory.

Metacognitive Practices - Insights

Deb Hagen-Moe, Education Coordinator at Mayo Clinic, discusses how metacognition can be used to enhance an individual’s ability to learn and retain information.

Sponsored testing - Insights

Learn about our sponsored testing program and how it can benefit both patients and healthcare providers.

Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D. - Insights

Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy...

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights

Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D. - Insights

Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these...